tirzepatide caremark Petition · Stop CVS Caremark's Zepbound Ban — Restore Coverage of the Superior Obesity Medication CVS hit with lawsuit over
Description
Only injectable tirzepatide is FDA-approved, under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for weight management)
Even at lower doses, significant weight loss has been observed across multiple studies
Participants who had been on the medication for 36 weeks (average weight loss of 20.9%) were then randomized to continue or switch to placebo
This too is a great finding: Bringing blood pressure under control is one of the challenges of treating type 2 diabetes
